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      Thyrotoxicosis is a condition in which tissues are stimulated by increased secretion of thyroid 
hormone. The most common cause is diffuse toxic goiter and toxic multi-nodular goiter. For more 
reviews on this disease, the effects of hyperthyroidism on liver enzyme levels were studied. A total of 30 
adult male Wistar rats weighing about 190 g were purchased from the Pasteur Institute of Iran. In this 
study, rats were divided into control group, the group receiving vitamin E, the group receiving 
levothyroxine, the group receiving levothyroxine treated with vitamin E; blood was taken from all 
groups over a period of 10 days after injection, and measurement of thyroid hormones and liver tests was 
made. The findings obtained in this study show that Isolated systolic hypertension (ISH) hormone levels 
in rats treated with levothyroxine, Treatment with vitamin E may reduce serum levels of ISH , Hormone 
levels of T4 in the rats treated with levothyroxine were increased compared to normal rates. Treatment 
with vitamin E reduces serum levels of T4 compared to the first hyper group. T4 hormone levels in rats 
treated with levothyroxine were reduced compared to normal rates. Treatment with vitamin E may 
reduce serum levels of T4 compared with the first hyper group. Asparagine Transferase (AST) enzyme 
levels in rats treated with levothyroxine were increased compared, Treatment with vitamin E may reduce 
serum levels of AST , Alanine transferase (ALT) enzyme levels in rats treated with levothyroxine were 
increased , Treatment with vitamin E may increase serum levels of ALT , alkaline phosphatase (ALP) 
enzyme levels in rats treated with levothyroxine has been increased compared with normal rates. 
Treatment with vitamin E resulted in serum levels of ALT not to be increased compared with the first 
group. According to the results of hyperthyroidism and levels of liver enzymes, it can be concluded that 
hyperthyroidism induced by levothyroxine can increase the levels of hormones T3, T4 and Thyroid 
Stimulating Hormone (TSH), and then increase the levels of liver enzymes. Treatment of empirical 
samples with vitamin E is likely to reduce liver damages and prevent the increased levels of liver 
enzymes compared to empirical samples of hyperthyroidism which have been treated with vitamin E. 
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INTRODUCTION  
     Hyperthyroidism or thyrotoxicosis is a 
condition in which tissues are stimulated by an 
increased secretion of thyroid hormone. The 
most common cause of hyperthyroidism is 
diffuse toxic goiter and toxic multi-nodular 
goiter. Other causes are toxic adenoma, single 
and sometimes multiple adenomas of follicular 
cells, whose secretion and activity is dependent 
on isolated systolic hypertension (ISH). 
Increased metabolism in response to 
hyperthyroidism can cause oxidative damage to 
certain organs, including liver, heart and 
muscles. Thyroid function can be regulated by 
two hyperthyroid and interthyroid mechanisms. 
Thyroiditis, which increase in T3 and T4 during 
an inflammatory process and a transient 
hyperthyroidism, that along with a return to the 
stage of euthyroidism and finally 
hypothyroidism, is due to the destruction of the 
tumor caused by the frequent recurrence of 
 




inflammation.  Due to an unknown cause, T3 of 
thyrotoxicosis reduces  the increased normal 
levels of T3 and T4. Iodine-induced 
hyperthyroidism resulting from the prescription 
of supplementary iodine in people endemic 
goiter can lead to thyroid hormone [1]. 
In most cases, changes in the thyroid gland are 
similar to the cases that have arisen due to an 
increase in Thyroid Stimulating Hormone (TSH); 
however, the ISH concentration in almost all 
patients is less (no more) than normal, and 
sometimes the secretion of ISH reaches zero. [1] 
In addition, almost in all these patients, there are 
other substances which act like ISH. These 
materials, which are immunoglobulin antibodies, 
are connected to the membrane receptors of ISH. 
They cause the sequential activation of the cyclic 
adenosine monophosphate (cAMP) system of the 
cells, and can cause hyperthyroidism. These 
antibodies are called thyroid-stimulating 
immunoglobulins (TSI). TSI has the prolonged 
(12 h) stimulatory effect on the thyroid gland, but 
the stimulating effect of ISH is little more than 
one hour. TSI causes excessive secretion of 
thyroid hormone, and thyroid hormone also 
inhibits secretion of ISH from the anterior 
pituitary. Antibodies responsible for 
hyperthyroidism are probably due to the 
emergence of autoimmunity against thyroid 
tissue. Probably in a period of one's past life, 
thyroid cell antigens are released in large 
amounts of these cells, and produce antibodies 
against thyroid gland itself. [1] Graves' disease is 
usually seen in other names such as diffuse 
goiter, hyperthyroidism, infiltrative 
ophthalmopathy, and infiltrative dermopathy) 
[2]. Symptoms of hyperthyroidism may include 
increased irritability, intolerance to heat, 
increased sweating, mild to severe reduction and 
sometimes up to 79 Kg, varying degrees of 
diarrhea, muscle weakness, nervousness, extreme 
fatigue with inability to sleep, shaking hands [1]. 
The most accurate test for routine diagnosis of 
hyperthyroidism is a direct measurement of free 
T4 and T3 concentration of plasma using a radio 
immunoassay method [1]. The fastest way to 
treat hyperthyroidism is removing much of the 
thyroid gland by surgery [1-2]. Increased 
metabolism in response to hyperthyroidism can 
cause oxidative damage to certain organs, 
including liver, heart and muscles [3]. Despite 
numerous clinical studies about the relationship 
of hyperthyroidism with liver function, little 
empirical research has been made in this area. 
Considering that conditions of empirical studies 
are much more controlled, this study indicates 
the extent of the effect of liver dysfunctions 
during short-term hyperthyroidism on the liver 
enzyme levels. 
 
  MATERIALS AND METHODS 
      A total of 30 adult male Wistar rats weighing 
approximately 150 g was purchased from the 
Pasteur Institute of Iran, and were classified into 
groups of seven. Then, they were kept in separate 
cages and suitable conditions with temperatures 
of 22± 2°C and a light-dark cycle of 12 h of light 
and 12 h of darkness (LD 12:12) and relative 
humidity of 70-50 percent. After the rats reached 
a weight range of about 200-250 g, the test was 
started. In this study, rats were divided into 
control group, the group receiving vitamin E, the 
group receiving levothyroxine, the group 
receiving levothyroxine treated with vitamin E. 
Firstly, levothyroxine drug was used to induce 
hyperthyroidism. After this drug is injected 
intraperitoneally for 10 days, it causes an animal 
model of hyperthyroidism disease. Rats in the 
control group received normal food and water 
only during this period. At the second stage, the 
drug of levothyroxine with the previous dose was 
used along with vitamin E. At this point, the 
control group received only vitamin E; and the 
other group received only the levothyroxine 
intraperitoneally. Blood was taken from all 
groups over a period of 10 days after injection, 
and measurement of thyroid hormones and liver 
tests was made (Diagrams 6 - 5 - 4) [1-2]. 
How to work with T3 Monobind kit Stages of 
tests T3 kit 
50 µl of the standard sample were poured for the 
control into the wells. 100 µl of conjugate 
solution of T3 were added to all wells. The plate 
gently was shaken for 20-30 seconds with the 
hand until conjugated solution was well mixed 
with serum. Then the surface of the wells was 
covered to avoid evaporation during incubation, 
the plate was incubated for 60 min at room 
temperature. The contents of the plate were 
emptied. 300 µl of diluted washing solution 
Added to all wells and then drained them. This 
procedure was performed three times. 100 µl of 
the prepared substrate solution (mixture of A and 
B) were added to all wells. The plate was 
incubated for 15 min at room temperature in a 
dark environment. 50 µl of STOP solution were 
added to all wells, and the plate was gently 
shaken for 15-20 seconds with the hand on the 
 




table surface. The plate was read at a wavelength 
of 790 nm (reference wavelength of 520 nm). 
OD of calibrators and curves in the brochure of 
the kit was given as an example; since incubation 
of the kit was done at room temperature, 
temperature and other parameters of the 
laboratory naturally affect on your optical density 
(OD) (Diagram 3). 
How to work with T4 Monobind kit Stages of 
tests T4 kit 
25 µl of the standard sample were poured for the 
control into the wells. 100 µl of conjugate 
solution of T4 were added to all wells. The plate 
was shaken gently for 20-30 seconds with the 
hand on the table surface until the conjugate 
solution was well mixed with serum. Then the 
surface of the wells was covered to avoid 
evaporation during incubation, the contents of 
the wells. The plate was incubated for 60 min at 
room temperature. The contents of the plate were 
emptied. 300 µl of diluted washing solution was 
added to all wells and then drained. The above 
procedure performed three times. 100 µl of the 
prepared substrate solution (mixture of A and B) 
were added to all wells. The plate was incubated 
for 15 min at room temperature in a dark 
environment. 50 µl of STOP solution were added 
to all wells, and the plate was gently shaken for 
15-20 seconds with the hand on the table surface. 
The plate was read at a wavelength of 450 nm 
(reference wavelength of 620 nm). OD of 
calibrators and curves in the brochure of kit were 
given as examples; since incubation of the kit 
was done at room temperature, temperature and 
other parameters of the laboratory naturally 
affect on the OD (Diagram 3). 
How to work with TSH Monobind kitStages of 
tests TSH kit 
50 µl of the standard sample were poured for the 
control into the wells. 100 µl of conjugate 
solution of TSH were added to all wells. The 
plate was shaken gently for 20-30 seconds with 
the hand on the table surface until the conjugate 
solution was well mixed with serum. Then the 
surface of the wells was covered to avoid 
evaporation during incubation, the contents of 
the wells. The plate was incubated for 60 min at 
room temperature. The contents of the plate were 
emptied. 300 µl of diluted washing solution was 
added to all wells and then drain them. The 
above procedure should be performed five times. 
100 µl of the prepared substrate solution (mixture 
of A and B) were added to all wells. The plate 
was incubated for 15 min at room temperature in 
a dark environment. 50 µl of STOP solution were 
added to all wells, and the plate was gently 
shaken for 15-20 seconds with the hand on the 
table surface. The plate was read at a wavelength 
of 450 nm (reference wavelength 620 nm). OD 
of calibrators and curves in the brochure of kit 
were given as examples; since incubation of the 
kit was done at room temperature, temperature 
and other parameters of the laboratory naturally 
affect on the OD (Diagram 3). After removal of 
the liver through surgery, its cross-section was 
placed in 10% formalin. According to 
conventional methods, the necessary sections 
were prepared, and were stained with 
hematoxylin and eosin (Figure 1.2.3). 
 
 RESULTS 
     After measuring the serum level of aspartate 
aminotransferase (AST) and the serum level of 
Alanine Transferase (ALT) and the serum level 
of alkaline phosphatase (ALP), all data were 
statistically evaluated using one-way ANOVA 
and Tukey test. 
Results were presented as Mean±S.E.M. The 





Diagram 1. Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats’ weight) and 
vitamin E (1 cc) on TSH levels in male Wistar rats. 
Con: control           hyper: hyperthyroidism 
   
 
Diagram 2. Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats’s weight) and 
vitamin E (1 cc) on T4 levels in male Wistar rats. 
Con: control           hyper: hyperthyroidism 
 
 





Diagram 3.  Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats 'weight) and 
vitamin E (1 cc) on T4 levels in male Wistar rats. 
Con: control           hyper: hyperthyroidism 
 
  
Diagram 4. Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats’ weight) and 
vitamin E (1 cc) on AST enzyme levels in male Wistar rats 
Con: control           hyper: hyperthyroidism 
 
 
Diagram 5.  Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats’ weight) and 
vitamin E (1 cc) on ALT enzyme levels in male Wistar 
rats. 




Diagram 6.  Effect of 10-day injection of levothyroxine 
(with a dose of 0.01 mg per kg of the rats’ weight) and 
vitamin E (1 cc) on ALT enzyme levels in male Wistar 
rats. 
 Con: control           hyper: hyperthyroidism 
 
Figure 1.  tissue section of the liver in a group that only 
received levothyroxine. Moderate inflammation in the 
port areas with mild fibrosis in the port area of 
inflammation and mild parenchymal edema as well as 
bile ducts. 
 
                   
 
Figure 2.  tissue section of the liver in a group that 
received vitamin E with levothyroxine. Mild to moderate 
inflammation and fibrosis of port areas; an increase in 
the small bile areas Vacuolation of hepatocytes were not 
seen. Parenchymal veins were dilated and increased 
Kupffer cells were observed. 
             
Figure 3.  tissue section of the liver in a group that only 
received vitamin E. Moderate inflammation of the port 
area with mild to moderate fibrosis, as well as a mild 
inflammation of the parenchyma In addition, the veins 
were dilated in the sample. 
 
DISCUSSION  
       Increased metabolism in response to 
hyperthyroidism can cause oxidative damage to 
certain organs, including liver, heart and 
muscles [3]. Weight loss despite increased 
appetite is a classic symptom of thyrotoxicosis 
that has been proven by laboratory and clinical 
studies. 
Clinical studies also suggest the effect of 
hyperthyroidism on the function of liver 
enzymes. Most sensitive and most widely used 
liver enzymes are aminotransferases, the most 
important of which are Aspartate amino 
Transferase (AST) and Alanine Transferase 
(ALT). Paul D. Bartels et al. studied the 
gluconeogenesis and ketogenesis in the liver of 
rats in 1980, and found that thyroid hormone 
 




changes gluconeogenesis and ketogenesis in the 
liver of rats injected; and possibly higher levels 
of thyroid hormones decrease gluconeogenesis 
and ketogenesis [4]. C. Landriscina and F. M. 
Ruggiero (1990) studied the formation of lipids 
in mitochondria and microsoma of liver in 
hyper thyroid rats. A significant reduction in 
cholesterol levels was observed in organelles of 
liver in hyperthyroid rat; lower cholesterol and 
phospholipid were observed in microsome [5]. 
Effects of antioxidant drugs on the potential 
dysfunctions caused by hyperthyroidism can be 
useful and instrumental, because it may suggest 
that antioxidant drugs can prevent damage to 
the liver in patients with hyperthyroidism – the 
aspect which is clinically very important. Thus, 
in the first step of the study, the effect of 
levothyroxine-induced hyperthyroidism on liver 
enzymes was studied. To this end, we 
intraperitoneally injected the levothyroxine drug 
for 10 days with a single dose. In 2007, A. 
Tanaka, T. Kawakani et al. observed 
levothyroxine-induced liver injury in patients 
with primary hypothyroidism, which had spent 
two months of treatment with the drug [6]. The 
study of Grasil.kraupp and g.lozano on the 
protective effects of vitamin E on liver in 2002 
showed that the vitamin is a useful antioxidant 
that can help reduce liver fibrosis, biliary atresia 
and inflammation of liver parenchyma. In the 
second stage, the effects of antioxidant drugs 
(vitamin E, for example) on the activities of 
liver enzymes were evaluated in an animal 
model of hyperthyroidism disease, which was 
induced by levothyroxine. In this stage, in 
addition to the intra peritoneal injection of 
levothyroxine with the same previous dose of 
vitamin E, they were also treated by gavage. 
After a few days, blood was taken from 
ventricles of both groups, and the experimental 
results suggest high levels of thyroid hormones, 
including ALP, ALT and AST, as the result of 
levothyroxine injection in comparison with the 
control group. Also, examining the enzyme 
levels of liver in blood (including ALT, AST 
and ALP) indicates high levels of these 
enzymes in hyperthyroid rats compared with the 
control rats. Several studies have been 
conducted on the effects of thyroid hormones in 
the liver. Studies show that thyroxine and 
triiodotyronine hormones can affect many 
functions of the liver. Most of these effects may 
be mediated due to binding of thyroid hormones 
to nuclear receptors for thyroid hormone. After 
binding of thyroid hormones to nuclear 
receptors, gene expression is affected. Some are 
active in their expression, and some are 
suppressed [7-8]. On the other hand, recent 
studies show that thyroid hormones can affect 
expression levels of thyroid receptors [9]. There 
are reports showing that thyroid hormones 
cause the phosphorylation and 
dephosphorylation of many cytosol proteins. 
Studies show that the activity of protein of 
kinase A (protein of kinase associated with 
cAMP in the liver of rats with hyperthyroidism) 
is one and a half times the rats with 
hypothyroidism [10]. Most studies have been 
conducted on the effect of thyroid hormones on 
the rate of metabolism [3]. This cellular damage 
usually occurs when the balance of oxidants and 
antioxidants in the body is disturbed, and the 
antioxidant system of the body is not able to 
neutralize these oxidants. In this case, the 
increase in oxidative stresses causes 
peroxidation of lipids, damage to proteins and 
DNA fragmentation [11]. In the year 1999, Nal-
erden and avsen akalm studied the effects of 
propyl-thyracil, propranolol and vitamin E on 
lipid peroxidation and antioxidant states in 
patients with hyper thyroid. Previous studies 
have shown that substances such as melatonin 
can prevent liver damage induced by thyroid 
dysfunctions (such as increased peroxidation of 
lipids) by increasing the rate of elimination of 
free radicals and directly increasing antioxidant 
activity [11-12]. So to gain a similar experience 
with the aim of examining the effect of 
antioxidants in reducing liver injury in the 
second stage of the study, the experienced rats 
received a certain dose of vitamin E by gavage, 
while levothyroxine with the previous dose was 
intraperitoneally injected into them. After the 
treatment period and after a few days of rest, 
blood was also taken from the ventricle of this 
group. As it was said in the previous chapter, 
the results suggest that T3, T4, and TSH 
hormone levels in hyper rats treated with 
vitamin E were reduced compared to hyper rats. 
In addition, serum levels of AST in hyper rats 
treated with vitamin E were decreased 
compared to the first group i.e. hyper (with 
vitamin E); i.e. treatment with vitamin E 
prevents the increase in serum levels of AST. 
Serum levels of ALT in hyper rats treated with 
vitamin E were increased compared to the first 
hyper group; i.e. treatment with vitamin E may 
increase serum levels of ALT. Serum levels of 
 




ALP in hyper rats treated with vitamin E were 
not increased compared to the first group. 
Studies show that thyroid hormones play an 
important role in the normal functioning of the 
digestive tract. There is abundant evidence in 
which thyrotoxicosis can cause abnormalities of 
liver function after examining slices of liver 
tissue from hyper thyroid samples [13-14]. V. 
Gnoni in 2000 observed cases of edema and 
inflammation of bile ducts and liver 
parenchyma as well as the cholestasis [15]. 
Liver damage that can be seen in 
hyperthyroidism has a wide range - from the 
mild abnormalities in function to liver ischemia 
[14-16]. As it is given in the section of Results 
with the figures for each case, changes in liver 
tissue in all three cases in this study (group 
receiving the levothyroxine drug, group 
receiving the drug of vitamin E and the group 
who received only vitamin E) were examined. 
Moderate inflammation and mild fibrosis in port 
areas, the increase in the small bile areas, as 
well as parenchymal inflammation and edema, 
and bile ducts were reduced in hyper thyroid 
rats. In the group receiving vitamin E with 
levothyroxine, mild inflammation and fibrosis 
in port areas as well as increased Kupffer cells 
were observed. Although parenchymal veins 
were dilated, parenchymal inflammation and 
edema were less. In a group that only received 
vitamin E, there was mild inflammation found 
in the port area and the parenchyma; and 
parenchymal veins were dilated. In the year 
1987, Gavm Artel and assistants reported that in 
hyperthyroidism rats, the number of damaged 
liver cells was decreased after 2-month intake of 
vitamin E [17]. Recent studies indicate that 
hyperthyroidism induces apoptosis in the liver 
of rats. In 2005, Ashok kumar et al. studied the 
induction of apoptosis in rat liver by hyper 
hypothyroidism via activation of the death 
pathway of mediated receptor). This study 
showed that hypothyroidism can induce cell 
death (by receptors such as neurotrophin 
receptor p75 of a member of the family of TNF 
receptors in rat liver). Recent studies indicate 
that in triiodotyronine-induced hyperthyroidism, 
internal pathway of apoptosis is activated by a 
direct effect of triiodotyronine hormones on 
mitochondria [18]. It is clear, according to the 
studies, that in triiodothyronine-induced 
hyperthyroidism, the extracellular factors 
inducing cell death (such as Tumor necrosis 
factor (TNF) and Fas) are increased, and can 
cause damage to liver cells through the 
activation of an external pathway of apoptosis. 
Therefore, according to the results of this 
experiment and the summarized results of 
similar experiments by other researchers in 
relation to the hyperthyroidism and levels of 
liver enzymes, it can be concluded that 
hyperthyroidism induced by levothyroxine can 
increase the levels of hormones T3, T4 and 
TSH, and then increase the levels of liver 
enzymes. Treatment of empirical samples with 
vitamin E is likely to reduce liver damages and 
prevent the increased levels of liver enzymes 
compared to empirical samples of 
hyperthyroidism which have been treated with 
vitamin E.  
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